亚辉龙、天晟新材被证监会立案调查,均涉信息披露违法违规
Xin Lang Cai Jing·2026-02-08 15:13

Core Viewpoint - Both Yahui Long (688575.SH) and Tiansheng New Materials (300169.SZ) have been officially investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, highlighting a significant regulatory crackdown on misleading announcements in the market [1][2][3]. Group 1: Company Investigations - Yahui Long's investigation is closely related to misleading statements in announcements regarding its strategic cooperation with Brain Machine Starlink Technology Co., which is linked to the trending concept of "brain-computer interfaces" [2][3]. - Tiansheng New Materials is under investigation for potentially undisclosed related party transactions in its historical financial information, with the specifics of the violations still pending further verification [3]. Group 2: Market Impact - Yahui Long's stock has experienced a downward trend, with a reported price of 14.45 yuan per share as of February 6, reflecting an 11.13% decline over the past three months and a 68.22% drop over the past five years [4]. - The company has also projected a significant decline in net profit for 2025, forecasting a 90.05% decrease, primarily due to industry policy adjustments and asset impairment losses, exacerbated by the ongoing investigation [4]. Group 3: Regulatory Environment - The simultaneous investigations of Yahui Long and Tiansheng New Materials are part of a broader trend, with eight listed companies or their actual controllers being investigated by the CSRC since the beginning of 2026, indicating a stringent regulatory environment [4][5]. - The focus of regulatory scrutiny includes misleading statements, market manipulation, and significant omissions, with Yahui Long's actions being a prime example of the type of behavior that regulators are targeting [5].

Shenzhen YHLO Biotech -亚辉龙、天晟新材被证监会立案调查,均涉信息披露违法违规 - Reportify